Traditional allografts

portfolio

Stryker continues to develop innovative technologies to enhance our spectrum of products, while collaborating with industry-leading tissue organizations to offer a robust portfolio of proprietary spinal grafts, viable bone matrices, demineralized bone matrix products, structural allografts, and large segmental, reconstructive allografts.

Stryker Biologics provides a comprehensive portfolio of allografts to accommodate a variety of clinical application and procedural needs. This portfolio consists of structural, large segmental and reconstructive grafts.

Contact

Related categories